<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04172116</url>
  </required_header>
  <id_info>
    <org_study_id>2235/2018</org_study_id>
    <nct_id>NCT04172116</nct_id>
  </id_info>
  <brief_title>Continuous Glucose Monitoring (CGM) After Surgical Variations of the Roux-en-y Gastric Bypass</brief_title>
  <official_title>Continuous Glucose Monitoring (CGM) After Surgical Variations of the Roux-en-y Gastric Bypass: Comparing Tissue Glucose Levels Between Two Surgical Bypass Methods - a Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the difference in post prandial tissue glucose levels between two
      variation of Roux-en-Y Gastric bypass by continuous glucose monitoring.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2020</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Tissue glucose levels</measure>
    <time_frame>6 days</time_frame>
    <description>Difference in tissue glucose levels after the two variations of the Roux-en-y Gastric bypass</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>tissue vs. blood glucose levels</measure>
    <time_frame>1 day</time_frame>
    <description>Comparison of tissue and blood glucose levels</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">68</enrollment>
  <condition>Continuous Glucose Monitoring</condition>
  <condition>Roux-en-y Gastric Bypass</condition>
  <condition>Hypoglycemia</condition>
  <arm_group>
    <arm_group_label>long pouch RYGB</arm_group_label>
    <description>Patients with the variation of a long and narrow pouch (hypothesis: slower transit of food)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>short pouch RYGB</arm_group_label>
    <description>Patients with the variation of a short and wide pouch (hypothesis: faster pouch emptying as compared with long and narrow pouch)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous glucose monitoring</intervention_name>
    <description>see arm/group descriptions</description>
    <arm_group_label>long pouch RYGB</arm_group_label>
    <arm_group_label>short pouch RYGB</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood chemistry testing for blood glucose levels
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Of each bariatric-metabolic operation we plan to include 34 patients. Of these 34 patients
        we plan to include also patients in each group with a diagnosed Diabetes mellitus type II
        at the time of operation (defined by either HbA1c &gt;6.5 or any medication or impaired
        fasting blood glucose level)

          1. Roux-en-y gastric bypass with long ang narrow pouch (&quot;long pouch RYGB&quot;)

          2. Roux-en-y gastric bypass with short and broad pouch (&quot;short pouch RYGB&quot;)

        Patients in the two RYGB groups will be matched for sex, age, comorbidities and BMI at the
        time of operation.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients who underwent bariatric-metabolic surgery at the Medical University of Vienna
             in the years 2012-2016 for the &quot;long and narrow&quot; pouch group

          2. Patients who underwent bariatric-metabolic surgery at the Clinic of Hollabrunn in the
             years 2010- 2012 for the &quot;short and wide&quot; pouch group

          3. Patients on oral medication for diabetes mellitus (for subgroup assessment)

          4. Stable weight (not more than + 15kg from lowest weight postoperatively)

          5. Stable BMI

        Exclusion Criteria:

          1. Unable to give written informed consent

          2. Patients with methods other than RYGB

          3. Reoperation within the observed period

          4. Any intervention changing pouch size or diameter of the anastomosis after the initial
             operation

          5. Known allergy to oral contrast agent

          6. Any regular intake of medication interfering with blood glucose levels
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerhard Prager, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Vienna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gerhard Prager, MD</last_name>
    <phone>0043 40400 56210</phone>
    <email>gerhard.prager@muw.ac.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julia Jedamzik, MD</last_name>
    <phone>0043 40400 56210</phone>
    <email>julia.jedamzik@muw.ac.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Landesklinikum Weinviertel Hollabrunn</name>
      <address>
        <city>Hollabrunn</city>
        <zip>2020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <contact>
      <last_name>Phillip Beckerhinn, MD</last_name>
      <email>chirurgie@hollabrunn.lknoe.at</email>
    </contact>
    <contact_backup>
      <last_name>Franz Hoffer, MD</last_name>
      <email>chirurgie@hollabrunn.lknoe.at</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 19, 2019</study_first_submitted>
  <study_first_submitted_qc>November 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 21, 2019</study_first_posted>
  <last_update_submitted>November 19, 2019</last_update_submitted>
  <last_update_submitted_qc>November 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Gerhard Prager</investigator_full_name>
    <investigator_title>Univ.Doz.Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>metabolic surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoglycemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

